Reuters logo
BRIEF-Tetraphase Pharmaceuticals completes enrollment of ignite4 phase 3 clinical trial of eravacycline in complicated intra-abdominal infections
2017年4月3日 / 中午12点26分 / 8 个月前

BRIEF-Tetraphase Pharmaceuticals completes enrollment of ignite4 phase 3 clinical trial of eravacycline in complicated intra-abdominal infections

April 3 (Reuters) - Tetraphase Pharmaceuticals Inc

* Tetraphase Pharmaceuticals completes enrollment of ignite4 phase 3 clinical trial of eravacycline in complicated intra-abdominal infections

* Tetraphase Pharmaceuticals Inc says expects to report top-line data from ignite4 phase 3 clinical trial in Q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below